Ouro Fino Saúde Animal Participações S.A (OFSA3) - Total Assets
Based on the latest financial reports, Ouro Fino Saúde Animal Participações S.A (OFSA3) holds total assets worth R$1.63 Billion BRL (≈ $320.00 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Ouro Fino Saúde Animal Participações S.A (OFSA3) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Ouro Fino Saúde Animal Participações S.A - Total Assets Trend (2011–2025)
This chart illustrates how Ouro Fino Saúde Animal Participações S.A's total assets have evolved over time, based on quarterly financial data. See OFSA3 book value for net asset value and shareholders' equity analysis.
Ouro Fino Saúde Animal Participações S.A - Asset Composition Analysis
Current Asset Composition (December 2025)
Ouro Fino Saúde Animal Participações S.A's total assets of R$1.63 Billion consist of 65.4% current assets and 34.7% non-current assets.
| Asset Category | Amount (BRL) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$0.00 | 16.0% |
| Accounts Receivable | R$430.37 Million | 27.5% |
| Inventory | R$303.64 Million | 19.4% |
| Property, Plant & Equipment | R$0.00 | 0.0% |
| Intangible Assets | R$105.22 Million | 6.7% |
| Goodwill | R$618.00K | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Ouro Fino Saúde Animal Participações S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OFSA3 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ouro Fino Saúde Animal Participações S.A's current assets represent 65.4% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 16.0% of total assets in 2025, up from 7.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 27.5% of total assets.
Ouro Fino Saúde Animal Participações S.A Competitors by Total Assets
Key competitors of Ouro Fino Saúde Animal Participações S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥13.81 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.56 Billion |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
China | CN¥5.91 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
Ouro Fino Saúde Animal Participações S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.46 | 2.56 | 3.82 |
| Quick Ratio | 2.41 | 1.44 | 2.40 |
| Cash Ratio | 0.00 | 0.46 | 0.87 |
| Working Capital | R$780.82 Million | R$472.27 Million | R$466.24 Million |
Ouro Fino Saúde Animal Participações S.A - Advanced Valuation Insights
This section examines the relationship between Ouro Fino Saúde Animal Participações S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.99 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 13.1% |
| Total Assets | R$1.57 Billion |
| Market Capitalization | $273.99 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ouro Fino Saúde Animal Participações S.A's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ouro Fino Saúde Animal Participações S.A's assets grew by 13.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ouro Fino Saúde Animal Participações S.A (2011–2025)
The table below shows the annual total assets of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | R$1.57 Billion ≈ $307.24 Million |
+13.08% |
| 2024-12-31 | R$1.38 Billion ≈ $271.70 Million |
+8.26% |
| 2023-12-31 | R$1.28 Billion ≈ $250.96 Million |
-5.01% |
| 2022-12-31 | R$1.35 Billion ≈ $264.21 Million |
+12.90% |
| 2021-12-31 | R$1.19 Billion ≈ $234.02 Million |
+8.04% |
| 2020-12-31 | R$1.10 Billion ≈ $216.61 Million |
+26.96% |
| 2019-12-31 | R$869.54 Million ≈ $170.62 Million |
+2.78% |
| 2018-12-31 | R$846.01 Million ≈ $166.00 Million |
+4.42% |
| 2017-12-31 | R$810.23 Million ≈ $158.98 Million |
+4.47% |
| 2016-12-31 | R$775.58 Million ≈ $152.18 Million |
+11.86% |
| 2015-12-31 | R$693.37 Million ≈ $136.05 Million |
+10.54% |
| 2014-12-31 | R$627.26 Million ≈ $123.08 Million |
+16.44% |
| 2013-12-31 | R$538.68 Million ≈ $105.70 Million |
+19.14% |
| 2012-12-31 | R$452.13 Million ≈ $88.72 Million |
-2.96% |
| 2011-12-31 | R$465.91 Million ≈ $91.42 Million |
-- |
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more